---
title: "300146.SZ (300146.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300146.SZ/news.md"
symbol: "300146.SZ"
name: "300146.SZ"
parent: "https://longbridge.com/en/quote/300146.SZ.md"
datetime: "2026-05-21T01:43:37.552Z"
locales:
  - [en](https://longbridge.com/en/quote/300146.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300146.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300146.SZ/news.md)
---

# 300146.SZ (300146.SZ) — Related News

### [Tmall Health, in collaboration with several leading brands, has launched the Health Supplement Assurance Alliance](https://longbridge.com/en/news/287041612.md)
*2026-05-20T09:48:42.000Z*
> On May 20th, it was reported that during the recent NHNE China International Health and Nutrition Expo, Tmall Health, in

### [Why did BYHEALTH suffer a major setback in the health supplement boom, shrinking by 3 billion in two years and losing its industry-leading position?](https://longbridge.com/en/news/286184504.md)
*2026-05-13T02:22:17.000Z*
> In the past two years, BYHEALTH's revenue has shrunk from 9.407 billion yuan to 6.265 billion yuan, resulting in a loss 

### [Soochow Securities Co., Ltd.: Initiates a "Buy" rating on BYHEALTH, believing that the current valuation still offers value for money](https://longbridge.com/en/news/286043601.md)
*2026-05-12T06:12:46.000Z*
> Soochow Securities Co., Ltd. has given BYHEALTH its first "Buy" rating, believing that its current valuation is cost-eff

### [Weikang Probiotics goes public in Hong Kong: Ranked third globally in original strain powder production, competing with international giants](https://longbridge.com/en/news/285808214.md)
*2026-05-09T10:04:15.000Z*
> Weikang Probiotics (Suzhou) Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange, becoming the seco

### [BYHEALTH: Plans to subscribe for warrants issued by Moonshot AI Ltd for USD 10 million](https://longbridge.com/en/news/285712904.md)
*2026-05-08T11:09:22.000Z*
> BYHEALTH announced that the company plans to use its own funds of USD 10 million to subscribe for the warrants issued by

### [With a market value evaporating by over 40 billion yuan and revenue growth without profit increase in the first quarter, how will BYHEALTH get through its "midlife crisis"? | Big Fish Finance](https://longbridge.com/en/news/285377442.md)
*2026-05-06T12:16:08.000Z*
> BYHEALTH's market value has evaporated by more than 40 billion yuan. In the first quarter of 2026, the operating revenue

### [Liang Yunchao reveals his scars: BYHEALTH's performance "beautification techniques" and growth traps](https://longbridge.com/en/news/284802617.md)
*2026-04-30T15:27:51.000Z*
> BYHEALTH faces a dual dilemma in 2026: on one hand, revenue in 2025 is expected to be 6.265 billion yuan, a year-on-year

### [In the first quarter, BYHEALTH's revenue stabilized while profits were under pressure, with online growth outpacing offline](https://longbridge.com/en/news/284542883.md)
*2026-04-29T09:54:12.000Z*
> BYHEALTH released its Q1 2026 report, with revenue of 1.869 billion yuan, a year-on-year increase of 4.3%, but net profi

### [For three consecutive quarters, revenue has increased year-on-year. BYHEALTH: Products are new, and channels are optimized](https://longbridge.com/en/news/284343426.md)
*2026-04-28T08:32:05.000Z*
> BYHEALTH released its first-quarter report, with revenue of 1.869 billion yuan, a year-on-year increase of 4.3%, achievi

### [[Huachuang Food and Beverage] BYHEALTH: Revenue continues to grow positively, investment pace disrupts profitability](https://longbridge.com/en/news/284141649.md)
*2026-04-27T02:19:41.000Z*
> BYHEALTH released its Q1 2026 report, with total operating revenue of 1.869 billion yuan, a year-on-year increase of 4.3